Seven children, with a mean (SD) age of 4*6 (2.1) years, who as infants (21 (7.5) days) underwent near total (95-98%) pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) were studied. At birth all the infants were macrosomic. Four infants had been born after a difficult labour, of whom three had moderate birth asphyxia and respiratory distress. All had normal thyroid function. After surgery transient hyperglycaemia was manifest in six ofthe children and required insulin treatment for 5-8 (3.8) weeks, and transient hypoglycaemia was encountered in one child and responded well to increased carbohydrate intake and diazoxide for three weeks. Six of the children rapidly crossed down their length and weight centiles during the first year after surgery. At the end of the first year these children were at or below the 5th centile of height and weight for their age and gender. After a period of 4-6 (2.1) years, their mean (SD) height score was -2 57 (0.5), growth velocity 3-9 (0.75) cm/year, and growth velocity SD score -2-1 (0.55)1 these were
significantly low and denoted significant growth retardation. The growth hormone peak responses to provocation with clonidine were normal (13-5 (2.8) pg/I). However, the circulating insulin-like growth factor-I (IGF-I) concentrations were significantly decreased (79 (34) ng/ml). Three of the children developed diabetes at two and a half, five, and seven years after surgery, two others had impaired oral glucose tolerance and six out of the seven children had an impaired C peptide response to glucagon. Defective insulin secretion in these children might directly inhibit IGF-I synthesis in the liver. The body mass index of the pancreatectomised children was (0.5) and was normal for age and gender; they had a normal 72 hour faecal fat content and normal serum albumin concentration. These data indicated grossly adequate exocrine pancreatic function. It appears that children requiring near total pancreatectomy for PHHI have normal developmental milestones but defective linear growth with impaired insulin secretion and low IGF-I production despite normal growth hormone response to provocation.
Persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) or nesidioblastosis is a diagnosis of importance as hypoglycaemia may be exceedingly difficult to control, and associated with it is a high incidence of brain damage and subsequent mental retardation.1 2 In nesidioblastosis there is a continued uncontrolled proliferation of pancreatic ductular endocrine cells replacing the normal islets and infiltrating the acinar tissue.3 Unlike the gradual increase of insulin release from the normal islet cells, [3] [4] [5] insulin secretion from the isolated nesidioblastosis cells is effectively autonomous.2 The hormone is released at a high rate even in the absence of secretagogues.6 Moreover, abnormalities in the distribution and number of insulin, glucagon, somatostatin, and pancreatic polypeptide cells are reported.7 8 Taguchi et al classified nesidioblastosis on immunohistochemical basis into diffuse and focal types which correlated to the clinical outcome.9
Infants with PHHI have excessive insulin secretion in utero, but in contrast to infants of diabetic mothers, this secretion is sustained after the neonatal period.7 10 . I
Height SD score after ferase, alkaline phosphatase, calcium, phos-size at birth, six out of the seven children with phorus, and bicarbonate concentrations. The PHHI crossed down growth centiles for length serum was separated from the formed elements and weight during the first year after panby centrifugation and kept frozen at -20°C createctomy to be at the 5th centile or below.
until analysed for growth hormone, free After 4-6 (2.1) years of follow up their height thyroxine, thyroid stimulating hormone, and SD score was significantly low at -2-57 (0.5) insulin-like growth factor-I (IGF-I). An oral denoting statural growth impairment (figure) dose of clonidine (0-15 mg/M2) and intra-and significantly lower than midparental height venous dose of 0 5 mg tetracosactrin SD score. Their mean annual growth velocity (Synacthen, Ciba) were given and blood (3-9 (0 75) cm/year and growth velocity SD samples were collected every 30 minutes for score (-2.1 (0-55)) were significantly low. two hours for determination of growth Their mean BMI at 14-88 (0 6) was not hormone and cortisol concentrations. Human different from those for the healthy controls, growth hormone and IGF-I were measured by 15-8 (0 4). radioimmunometric assay, employing reagents Developmental evaluation, at a mean age of purchased from the Nichols Institute (San 4-6 (2.1) years, revealed that only one child Juan Capistrano, CA, USA). Intra-assay co-had mild mental retardation with delayed efficient of variation averaged 5-5 in the range motor and language development. The other of growth hormone values detected and 8-7% six patients had normal gross and fine motor in the range of IGF-I concentration measured. development. Their language development Free thyroxine, thyroid stimulating hormone, and cognitive function were appropriate for and cortisol concentrations were measured their age. using Amerlex-RIA kits (Kodak Clinical Table 2 represents growth data of panDiagnostics). Glycated haemoglobin was createctomised children in comparison with 20 measured by the IMx glycated haemoglobin children with IDDM and 150 normal children assay (a boronate affinity binding assay) kits followed up for one year. The height SD score, (Abbot Laboratory Diagnostic Division). The annual growth velocity, and growth velocity normal range for the non-diabetic population SD score of pancreatectomised patients as well is 4-4-6-4%. After three days on full carbo-as their circulating IGF-I concentrations were hydrate diet and after an overnight fast, an oral significantly lower than those for children with glucose tolerance test was performed (1.75 g IDDM and for the laboratory normal range for glucose/kg body weight) and serum glucose healthy children between 1-6 years (195 estimated by glucose oxidase method before ng/ml). The glycated haemoglobin concenand one and two hours after the oral glucose trations were significantly higher in the panload. On the second morning serum C peptide createctomised and IDDM groups compared was determined before and six minutes after with the normal range of the laboratory data intravenous injection of 15 ug/lkg glucagon. for children between 1-6 years (4-6 (0-5)%). Exocrine pancreatic function was assessed by At the age of 4-6 (2. 1) years all children with 72 hour stool fat estimation.
PHHI had normal haemogram and hepatic, Statistical analyses were done using the renal, and thyroid functions. Serum albumin concentrations did not differ between patients (41 (5.2) g/l) and controls (42-5 (6-3) g/l). (mean fat 6a1 (0 6) g/day; normal 2-7 g/day). hypoinsulinaemia, after pancreatectomy might explain in part the rapid deceleration of growth in our children with PHHI during the first year after surgery. In support of this view, all our patients (numbers 2, 3, and 5) who were evaluated during the first year after surgery had impaired glucose tolerance and defective C peptide release after glucagon (peak C peptide 0.3, 068, and 0-85 ng/ml respectively). The possibility of compromised nutrition due to defective exocrine pancreatic secretion, especially during the few months after surgery, and its negative effect on IGF-I synthesis cannot be ruled out. 24 Infants of diabetic mothers who do not have exocrine pancreatic deficiency also show catchdown growth in the first year of life.45 In these infants poor feeding is a major problem that is often present and might be an important factor contributing to slowing of growth in these infants.46 Moreover, after major surgery the protein catabolic status might adversely affect growth especially during infancy. Recently this catabolic status has been prevented by administration of growth hormone/IGF-I treatment. 47 48 Dietary assessment during the first year after surgery, using the recall method for three days, revealed that six out of the seven infants had a normal appetite and consumed an adequate amount of milk and other food items (cereals, egg, vegetables, and meat/kg). Only one infant had severe anorexia and poor weight gain after the operation that necessitated gavage feeding for 10 days and pancreatic extract supplementation for eight weeks. During childhood they had grossly normal exocrine pancreatic function evidenced by normal 72 hour faecal fat excretion and their dietary intake was qualitatively and quantitatively normal. However, two children had a history of intolerance to dietary fat.
At a mean age of 4 6 (2.1) years height SD score, growth velocity, and growth velocity SD score were significantly low. Decreased IGF-I synthesis in these children can explain in part their impaired statural growth. IGF-I production is regulated mainly by growth hormone,49 but other hormones including insulin as well as the nutritional status contribute to this regulation.50 51 Despite the possibility of ischaemiclhypoxic insult to the hypothalamicpituitary axis during difficult labour and/or one or more of the hypoglycaemic seizure attacks, our patients have a proper growth hormone response to clonidine provocation, thus ruling out growth hormone deficiency. Their low basal and glucagon provoked C peptide Growth and endocrine fuinction after near total pancreatectomy for hyperinsulinaemic hypoglycaemia38 70 impose the possibility of pharmacotherapeutic intervention. [71] [72] [73] In summary, in children who undergo near total pancreatectomy for PHHI the regrowth of the 3 cell mass appears to be inadequate for maintainingr longc rter glycaemic control, wi7th a high incidence of impaired glucose tolerance and IDDM during childhood. This defective insulin secretion appears to be an important cause of their impaired statural growth; however, their neurodevelopmental outcome is satisfactory.
Surgery for drooling
Drooling is said to be a problem in between 10 and 37% of children with cerebral palsy. It is messy, often unsightly, and sometimes smelly. It causes chronic irritation of facial skin, adds to the burden of care, and may cause embarrassment and loss of self esteem.
The ins and outs of surgical treatment have been debated for some years. Surgical options include, alone or in combination, removal of salivary glands, ligation of salivary ducts, transposition of salivary ducts, and division of salivary gland nerve supply.
In Victoria, Australia, the favoured procedure has been transposition of the submandibular ducts into the tonsillar fossas and ligation of one parotid duct (Kerri-lyn Webb and colleagues, Developmental Medicine and Child Neurology 1995; 37: 755-62). Thirty nine patients underwent the operation: 31 with cerebral palsy, four with neurological impairment of other cause, and four with intellectual disability without motor impairment.
Judging solely by preoperative and postoperative measures of drooling the results over six years of follow up were good with between 77 and 100% of patients showing improvement on various measures. Nevertheless 38% had 'moderate to severe' or worse drooling after the operation and in only 23% was postoperative drooling absent or mild. Twelve patients said that surgery had not helped them. Eighteen said their saliva had become thicker and 20 frothier and some found this distressing. There may have been an increase in dental caries and minor infections after the operation and five patients needed further surgery for ranulas. Nine complained of a dry mouth with crusting of the lips and two had airway obstruction leading in one to intubation and admission to intensive care.
In the same issue of Developmental Medicine and Child
Neurology there is an editorial written by the president of the American Academy for Cerebral Palsy and Developmental Medicine calling for better outcome assessments and including the statement, 'We must listen to our patients to determine the kinds of outcomes that are important to improve the quality of their lives'. Yes, indeed.
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